| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2015 | 319 | 0.550 |
Why?
|
| Lymphoma, T-Cell | 2 | 2015 | 369 | 0.500 |
Why?
|
| Pathology, Molecular | 1 | 2015 | 124 | 0.480 |
Why?
|
| Immunophenotyping | 4 | 2016 | 1728 | 0.420 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2012 | 32 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2012 | 186 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2012 | 410 | 0.360 |
Why?
|
| Translocation, Genetic | 2 | 2015 | 1287 | 0.360 |
Why?
|
| PTEN Phosphohydrolase | 7 | 2009 | 1015 | 0.360 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2009 | 505 | 0.340 |
Why?
|
| Retroviridae Proteins, Oncogenic | 2 | 1998 | 41 | 0.320 |
Why?
|
| ras Proteins | 1 | 2012 | 797 | 0.310 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 2618 | 0.210 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2012 | 57 | 0.210 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2023 | 7226 | 0.200 |
Why?
|
| BRCA1 Protein | 1 | 2024 | 515 | 0.190 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2002 | 265 | 0.180 |
Why?
|
| Apoptosis | 5 | 2016 | 7854 | 0.180 |
Why?
|
| Chromosome Aberrations | 2 | 2011 | 2023 | 0.180 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2024 | 508 | 0.170 |
Why?
|
| Oncogene Proteins v-rel | 4 | 2006 | 7 | 0.170 |
Why?
|
| Mutation | 5 | 2018 | 15828 | 0.160 |
Why?
|
| Cysteine Endopeptidases | 2 | 2016 | 266 | 0.160 |
Why?
|
| Neoplastic Stem Cells | 3 | 2015 | 1469 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2018 | 3658 | 0.150 |
Why?
|
| Cloning, Molecular | 2 | 2006 | 1460 | 0.150 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2013 | 2468 | 0.150 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2018 | 237 | 0.140 |
Why?
|
| Proteins | 3 | 2009 | 2049 | 0.130 |
Why?
|
| Cell Proliferation | 8 | 2016 | 7297 | 0.130 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 1422 | 0.130 |
Why?
|
| Animals | 22 | 2024 | 62835 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2005 | 1885 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2014 | 178 | 0.120 |
Why?
|
| Tumor Suppressor Protein p14ARF | 2 | 2006 | 101 | 0.120 |
Why?
|
| Glycolysis | 1 | 2016 | 534 | 0.110 |
Why?
|
| Cytogenetic Analysis | 1 | 2015 | 574 | 0.110 |
Why?
|
| Receptors, Immunologic | 1 | 2015 | 316 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2008 | 1119 | 0.110 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 2012 | 12 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2016 | 9078 | 0.110 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2012 | 47 | 0.100 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2012 | 176 | 0.100 |
Why?
|
| Mice, Knockout | 7 | 2015 | 5837 | 0.100 |
Why?
|
| Hydroxyurea | 1 | 2012 | 223 | 0.100 |
Why?
|
| Cell Line, Tumor | 9 | 2024 | 14870 | 0.090 |
Why?
|
| Embryo Loss | 1 | 2010 | 42 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 527 | 0.090 |
Why?
|
| Genes, Lethal | 1 | 2010 | 131 | 0.090 |
Why?
|
| RecQ Helicases | 1 | 2010 | 97 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2012 | 839 | 0.090 |
Why?
|
| Leukemia, Experimental | 1 | 2009 | 83 | 0.090 |
Why?
|
| Mice | 14 | 2024 | 35983 | 0.090 |
Why?
|
| Glioblastoma | 3 | 2009 | 1773 | 0.080 |
Why?
|
| Haploidy | 1 | 2008 | 43 | 0.080 |
Why?
|
| Dyskeratosis Congenita | 1 | 2008 | 26 | 0.080 |
Why?
|
| Myocardium | 1 | 2014 | 1248 | 0.080 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 813 | 0.080 |
Why?
|
| Receptor, Notch1 | 1 | 2009 | 220 | 0.080 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2010 | 401 | 0.080 |
Why?
|
| Gene Deletion | 2 | 2014 | 1482 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2023 | 2905 | 0.080 |
Why?
|
| Humans | 27 | 2024 | 270852 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2011 | 2315 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2011 | 3079 | 0.070 |
Why?
|
| Chick Embryo | 3 | 2006 | 219 | 0.070 |
Why?
|
| Transfection | 3 | 2016 | 3168 | 0.070 |
Why?
|
| Brain Neoplasms | 3 | 2009 | 4966 | 0.070 |
Why?
|
| Genes, myc | 1 | 2009 | 374 | 0.070 |
Why?
|
| Genes, rel | 1 | 2006 | 8 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2012 | 1091 | 0.070 |
Why?
|
| Temperature | 2 | 1998 | 542 | 0.070 |
Why?
|
| Cell Differentiation | 3 | 2009 | 4191 | 0.070 |
Why?
|
| Histiocytic Disorders, Malignant | 1 | 2006 | 7 | 0.070 |
Why?
|
| Aging | 1 | 2014 | 1576 | 0.070 |
Why?
|
| Base Sequence | 4 | 2016 | 5498 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 7210 | 0.070 |
Why?
|
| DNA-Binding Proteins | 4 | 2010 | 5040 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 1409 | 0.060 |
Why?
|
| Telomerase | 1 | 2008 | 533 | 0.060 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2006 | 179 | 0.060 |
Why?
|
| Kidney | 1 | 2014 | 2338 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2012 | 4643 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2005 | 633 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2006 | 272 | 0.060 |
Why?
|
| Neurons | 2 | 2008 | 2462 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2010 | 2126 | 0.060 |
Why?
|
| Genes, p53 | 1 | 2009 | 1136 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 2413 | 0.060 |
Why?
|
| Liver | 1 | 2014 | 3127 | 0.060 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2014 | 1733 | 0.060 |
Why?
|
| Alleles | 3 | 2018 | 2507 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2012 | 6789 | 0.060 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2024 | 87 | 0.060 |
Why?
|
| Osteosarcoma | 1 | 2010 | 949 | 0.060 |
Why?
|
| Transformation, Genetic | 2 | 2002 | 70 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 3146 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 5404 | 0.050 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 2123 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2024 | 3918 | 0.050 |
Why?
|
| Lymphoma | 1 | 2010 | 1515 | 0.050 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 254 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 1998 | 3496 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2009 | 1328 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 3 | 2012 | 1215 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2009 | 6493 | 0.050 |
Why?
|
| RNA Interference | 2 | 2016 | 1398 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2010 | 3459 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 2006 | 957 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 1 | 2008 | 1146 | 0.050 |
Why?
|
| Carcinogenesis | 2 | 2018 | 1030 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2006 | 1274 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 5160 | 0.050 |
Why?
|
| Middle Aged | 7 | 2016 | 89908 | 0.050 |
Why?
|
| DNA Damage | 1 | 2008 | 1976 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2002 | 347 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2000 | 26 | 0.050 |
Why?
|
| Phenotype | 3 | 2014 | 6455 | 0.040 |
Why?
|
| Bone Marrow | 2 | 2023 | 2438 | 0.040 |
Why?
|
| I-kappa B Proteins | 1 | 2000 | 178 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2011 | 2322 | 0.040 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1998 | 49 | 0.040 |
Why?
|
| Carcinoma | 1 | 2010 | 2627 | 0.040 |
Why?
|
| Male | 8 | 2016 | 128407 | 0.040 |
Why?
|
| Pheochromocytoma | 1 | 2002 | 302 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2015 | 5835 | 0.040 |
Why?
|
| Heterozygote | 1 | 2002 | 1033 | 0.040 |
Why?
|
| Mice, SCID | 3 | 2009 | 1857 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2024 | 16173 | 0.040 |
Why?
|
| Astrocytes | 1 | 2002 | 405 | 0.040 |
Why?
|
| Signal Transduction | 5 | 2016 | 12205 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2016 | 843 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 1587 | 0.040 |
Why?
|
| ErbB Receptors | 2 | 2008 | 2372 | 0.040 |
Why?
|
| Caspase 1 | 1 | 1997 | 63 | 0.040 |
Why?
|
| Glioma | 1 | 2008 | 1963 | 0.040 |
Why?
|
| Female | 9 | 2024 | 148432 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2005 | 5503 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 1997 | 431 | 0.040 |
Why?
|
| Chickens | 1 | 1997 | 791 | 0.040 |
Why?
|
| Genome, Human | 1 | 2005 | 1835 | 0.040 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2002 | 522 | 0.040 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 1997 | 203 | 0.040 |
Why?
|
| Tumor Hypoxia | 1 | 2016 | 24 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 322 | 0.030 |
Why?
|
| Antibodies | 1 | 2000 | 837 | 0.030 |
Why?
|
| Cell Shape | 1 | 2016 | 129 | 0.030 |
Why?
|
| Remission Induction | 1 | 2023 | 3648 | 0.030 |
Why?
|
| Sumoylation | 1 | 2016 | 81 | 0.030 |
Why?
|
| Macrophages | 1 | 2023 | 1369 | 0.030 |
Why?
|
| Cell Line | 2 | 2006 | 5436 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1997 | 949 | 0.030 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2016 | 163 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 374 | 0.030 |
Why?
|
| Retroviridae | 2 | 2009 | 376 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2015 | 15 | 0.030 |
Why?
|
| Prognosis | 3 | 2016 | 22421 | 0.030 |
Why?
|
| Neoplasms | 1 | 2002 | 15836 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2016 | 337 | 0.030 |
Why?
|
| Sarcoma | 1 | 2006 | 1822 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2015 | 58 | 0.030 |
Why?
|
| DNA Primers | 1 | 1997 | 1509 | 0.030 |
Why?
|
| Stem Cells | 1 | 2002 | 1229 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 634 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 380 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 401 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 196 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 414 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 5308 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2014 | 254 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 704 | 0.030 |
Why?
|
| Injections | 1 | 2014 | 289 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 582 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 304 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2000 | 1582 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 1 | 2012 | 81 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1997 | 879 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2005 | 11743 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 1046 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2012 | 3650 | 0.030 |
Why?
|
| Culture Media | 1 | 2012 | 339 | 0.020 |
Why?
|
| Time Factors | 2 | 2016 | 13122 | 0.020 |
Why?
|
| Transcription Factors | 3 | 2014 | 5491 | 0.020 |
Why?
|
| Young Adult | 3 | 2016 | 22014 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1084 | 0.020 |
Why?
|
| Neoplasm Proteins | 2 | 2005 | 3352 | 0.020 |
Why?
|
| Melanoma | 1 | 2009 | 5522 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 2979 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2016 | 9310 | 0.020 |
Why?
|
| Models, Animal | 1 | 2014 | 675 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2016 | 2108 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 594 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 4369 | 0.020 |
Why?
|
| Adult | 4 | 2016 | 81480 | 0.020 |
Why?
|
| Karyotyping | 1 | 2012 | 1065 | 0.020 |
Why?
|
| Blastocyst | 1 | 2010 | 144 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 4180 | 0.020 |
Why?
|
| Retina | 1 | 2014 | 554 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2014 | 907 | 0.020 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2009 | 46 | 0.020 |
Why?
|
| Aged | 4 | 2015 | 73012 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 1757 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2010 | 241 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2011 | 485 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 14680 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2008 | 2093 | 0.020 |
Why?
|
| Gene Expression | 1 | 1997 | 3682 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2009 | 101 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2016 | 13964 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 1539 | 0.020 |
Why?
|
| Hematopoietic System | 1 | 2008 | 26 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 12488 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 3080 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 1814 | 0.020 |
Why?
|
| Monocytes | 1 | 2012 | 787 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 30875 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 497 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2008 | 21 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2010 | 315 | 0.020 |
Why?
|
| Hippocampus | 1 | 2014 | 976 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 7460 | 0.020 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2008 | 109 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 306 | 0.020 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2009 | 275 | 0.020 |
Why?
|
| Neutrophils | 1 | 2012 | 870 | 0.020 |
Why?
|
| Laminin | 1 | 2008 | 212 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 665 | 0.020 |
Why?
|
| Species Specificity | 1 | 2009 | 811 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2009 | 242 | 0.020 |
Why?
|
| Adolescent | 2 | 2012 | 32578 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 912 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 4358 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2008 | 278 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 750 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6243 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2008 | 5785 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 387 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 512 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2008 | 435 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 917 | 0.020 |
Why?
|
| Cell Death | 1 | 2008 | 689 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2008 | 635 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 201 | 0.020 |
Why?
|
| Plasmids | 1 | 2008 | 952 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2006 | 133 | 0.020 |
Why?
|
| Telomere | 1 | 2008 | 534 | 0.020 |
Why?
|
| Collagen | 1 | 2008 | 738 | 0.020 |
Why?
|
| Cytogenetics | 1 | 2005 | 152 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 644 | 0.020 |
Why?
|
| Methylation | 1 | 2006 | 625 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 986 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 475 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2009 | 1773 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 3655 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2008 | 774 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2005 | 323 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 6022 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2006 | 1837 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2005 | 532 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 1036 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2008 | 1742 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2002 | 65 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 1986 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 1571 | 0.010 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2005 | 462 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2005 | 736 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2005 | 827 | 0.010 |
Why?
|
| Oncogenes | 1 | 2005 | 700 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 1725 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 309 | 0.010 |
Why?
|
| Homeostasis | 1 | 2006 | 961 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2000 | 138 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 704 | 0.010 |
Why?
|
| Homozygote | 1 | 2002 | 755 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 4988 | 0.010 |
Why?
|
| Dimerization | 1 | 2000 | 318 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2005 | 1229 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 2490 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 1651 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 3243 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2002 | 791 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 7817 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 15218 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 2250 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 16980 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2005 | 2953 | 0.010 |
Why?
|
| Lymphoma, B-Cell | 1 | 2000 | 935 | 0.010 |
Why?
|
| Child | 1 | 2012 | 30422 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2005 | 5567 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 7933 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 7929 | 0.000 |
Why?
|